SCHEMBL22990298

SCHEMBL22990298

O=C1NCCc2c(Br)cc(I)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 12/20 0.56
▸ PARP11 Q9NR21 8/20 0.56
▸ PARP1 P09874 9/20 0.44
▸ ACHE P22303 1/20 0.40
▸ RAF1 P04049 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAP2K1 Q02750 1/20 0.39
▸ PDPK1 O15530 1/20 0.37
▸ F7 P08709 1/20 0.37
▸ F3 P13726 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ CDK2 P24941 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ CSNK1A1 P48729 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ DYRK1B Q9Y463 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29698302 1.00 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL25411512 0.82 CLK4 (0.53) PARP10PARP11PARP1RAF1MAPK1
SCHEMBL30197872 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL29698189 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL30197575 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL24886285 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL23951998 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL23952300 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL22982047 0.79 PARP10 (0.56) PARP10PARP11PARP1ACHERAF1
SCHEMBL22981764 0.76 PARP10 (0.51) PARP10PARP11PARP1ACHERAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 — — WO disclosed
WO-2021028806-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 — — WO disclosed
Send feedback